Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer. (NCT03616587)

🧪 Interventions in This Study

• AZD9833 (DRUG)
• AZD9833 (DRUG)
• AZD9833 with palbociclib (DRUG)
• AZD9833 with palbociclib (DRUG)
• AZD9833 with everolimus (DRUG)
• AZD9833 with everolimus (DRUG)
• AZD9833 with abemaciclib (DRUG)
• AZD9833 with abemaciclib (DRUG)
• AZD9833 with capivasertib (DRUG)
• AZD9833 with capivasertib (DRUG)
• AZD9833 with ribociclib (DRUG)
• AZD9833 with ribociclib (DRUG)
• AZD9833 with anastrozole (DRUG)
• AZD9833 with anastrozole (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (17 Sites)

• Research Site — Aurora, Colorado
• Research Site — Sarasota, Florida
• Research Site — Philadelphia, Pennsylvania
• Research Site — Nashville, Tennessee
• Research Site — Salt Lake City, Utah
• Research Site — Barcelona,
• Research Site — Barcelona,
• Research Site — Madrid,
• Research Site — Madrid,
• Research Site — Seville,
• Research Site — Valencia,
• Research Site — Cambridge,
• Research Site — Leeds,
• Research Site — London,
• Research Site — Manchester,
• Research Site — Sutton,
• Research Site — Sutton,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in ER+ HER2- Advanced Breast Cancer

• A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors — St Louis, Missouri

Explore by condition: All ER+ HER2- Advanced Breast Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.